Celanese (CE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Mar, 2026Executive summary
Board and management focused on long-term shareholder value, financial flexibility, and strategic transformation, including divestitures and capital allocation priorities.
CEO emphasized operational excellence, cost discipline, and free cash flow as key financial objectives, with targeted portfolio actions to accelerate deleveraging.
Board refreshment continued, adding directors with diverse skills and recent C-suite experience, and maintaining a balance of tenure and expertise.
Active shareholder engagement addressed board leadership, governance, compensation alignment, and sustainability.
Voting matters and shareholder proposals
Shareholders will vote on the election of nine directors, ratification of KPMG LLP as independent auditor for 2026, and an advisory say-on-pay vote on executive compensation.
Board recommends voting FOR all director nominees, auditor ratification, and executive compensation approval.
Proxy access allows shareholders with 3% ownership for 3 years to nominate up to 2 directors or 20% of the board.
Board of directors and corporate governance
Board consists of nine nominees, eight of whom are independent; independent Chair and CEO roles are separated.
Board committees include Audit, Compensation and Management Development, Nominating and Corporate Governance, Stewardship, and Finance and Business Review.
Annual board and committee self-evaluations, majority voting standard, and no mandatory term limits.
Director compensation includes cash and equity, with robust stock ownership guidelines and annual reviews.
Latest events from Celanese
- Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.CE
Proxy Filing4 Mar 2026 - 2026 targets $650M–$750M free cash flow after strong 2025 cash generation and cost cuts.CE
Q4 202518 Feb 2026 - Q1 2025 net loss, cost cuts, and refinancing support $700–$800M free cash flow target.CE
Q1 20253 Feb 2026 - Q2 2024 delivered record Engineered Materials results and resilient earnings amid supply headwinds.CE
Q2 20242 Feb 2026 - Q3 profit drop, 95% dividend cut, and cost actions target deleveraging amid weak demand.CE
Q3 202416 Jan 2026 - 2024 loss on $10.3B sales, but cost cuts and deleveraging set stage for 2025 recovery.CE
Q4 202417 Dec 2025 - Shareholders to vote on board refreshment, governance reforms, and executive pay amid strategic transformation.CE
Proxy Filing1 Dec 2025 - Board refreshment, governance reforms, and ESG integration drive strategic transformation.CE
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, compensation, and key governance changes.CE
Proxy Filing1 Dec 2025